Winnipeg, MB – Cubresa Inc., a world leader in PET inserts for MRI, has selected a Chinese distributor for its NuPET™ preclinical imaging product line. Cubresa is pleased to announce that it has signed an agreement with Worldwide Technology (S.H.) Co., Ltd. (WAD), a Shanghai-based distributor who specializes in the sale of life sciences related equipment […]
WASHINGTON — Danaher Corporation (NYSE: DHR) (“Danaher” or the “Company”) announced today that it has entered into a definitive agreement with General Electric Company (“GE”) (NYSE: GE) to acquire the Biopharma business of GE Life Sciences (“GE Biopharma”) for a cash purchase price of approximately $21.4 billion. Given anticipated tax benefits from the transaction structure, the net […]
Valitacell, a biotechnology company transforming cell-based manufacturing, and Solentim, a global leader in cell line development instrumentation, today announced a new collaboration to enable earlier identification of biological candidates and to accelerate the development of breakthrough medicines. Valitacell’s novel in-line analytical profiling technologies and its data-driven/machine learning approach, together with Solentim’s innovative image-driven liquid handling […]
For a few years now, molecular biology has been completely dominated by single cell technologies. It all started with single cell RNA-Seq, but rapidly branched out to other applications, such as epigenomics, regulation (ATAC-Seq and ChIP-Seq), and proteomics (for a high-level overview, we suggest an excellent recent articlein Nature Reviews Genetics). Analysis of single cell data sets […]
Darrin M Disley, PhD, DSc, OBE, appointed as CEO New investment from Ahren Innovation Capital, 24Haymarket and Dr Disley Mogrify’s technology enables the conversion of any mature cell type into any other mature cell type without going through a pluripotent stem cell- or progenitor cell-state Promises to address the unmet market need for cell types […]
A major publicly traded life science tools company has entered a technology assessment agreement with Phase Holographic Imaging (PHI). The purpose of the agreement is to assess PHI’s HoloMonitor technology for cell biology applications, primarily within immuno-oncology. The assessment is expected to extend over at least six months and to form the basis of the […]
Oxford: Oxford Genetics and Sphere Fluidics announce a multi-partner collaboration to expedite the development of automated microfluidic systems for rapid and high-throughput gene editing in mammalian cell lines. Under the agreement, Sphere Fluidics will act as the lead partner, looking to utilise its extensive expertise in microfluidic systems to produce new products designed to meet the […]
Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and neurodegenerative disease, is delighted to announce that we will participate in BonePainII, a European Innovative Training Network committed to promote frontline research, innovation and education within bone pain. Millions of Europeans and beyond suffer from bone […]
Collaboration provides drug discovery researchers access to European distribution and local support for library of in-stock and on-demand compounds Riga, Latvia and Shanghai, China, February 13 2019: Chemspace and LabNetwork, a WuXi AppTec company, both online marketplaces for chemical compounds used in drug discovery, today announced they have entered into a collaboration agreement. Under the agreement,LabNetwork’s products will be available on www.chem-space.com, with distribution and […]
In June 2018, Phase Holographic Imaging (PHI) and BioSpherix Medical entered a collaboration agreement, aiming to co-market the companies’ complementary product lines. BioSpherix develops and markets advanced hermetically sealed cell incubators for the control and optimization of cell culture environments. Since most cell analysis instruments are not adapted to cope with the demanding environment within cell incubators, […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
